Literature DB >> 17640751

The eradication experience of enzootic bovine leukosis from Lithuania.

J Acaite1, V Tamosiunas, K Lukauskas, J Milius, J Pieskus.   

Abstract

Before 1985 the situation regarding enzootic bovine leukosis (EBL) in Lithuanian cattle was described only haphazardly. In 1986 serological investigations were initiated together with an eradication programme. The EBL bovine leukosis virus (BLV) situation was monitored by the Institute of Immunology Vilnius University, national and regional veterinary laboratories. Starting in 1986 all EBL-positive cattle were separated from negative cattle into BLV-infected and BLV-free herds. To create the latter, calves were fed pasteurized milk. The seroprevalence in 1990 was 7.29%, but it steadily declined to 0.32% in 2006.

Entities:  

Mesh:

Year:  2007        PMID: 17640751     DOI: 10.1016/j.prevetmed.2007.05.010

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  19 in total

1.  Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis.

Authors:  Asami Nishimori; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Shinya Goto; Ryoyo Ikebuchi; Ayako Nakahara; Yuzumi Chiba; Masaho Ikeda; Shiro Murata; Kazuhiko Ohashi
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

2.  An 8-year longitudinal sero-epidemiological study of bovine leukaemia virus (BLV) infection in dairy cattle in Turkey and analysis of risk factors associated with BLV seropositivity.

Authors:  Murat Şevik; Oğuzhan Avcı; Ömer Barış İnce
Journal:  Trop Anim Health Prod       Date:  2015-02-24       Impact factor: 1.559

Review 3.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

4.  Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease.

Authors:  Sarah Blickenstorfer; Heinzpeter Schwermer; Monika Engels; Martin Reist; Marcus G Doherr; Daniela C Hadorn
Journal:  BMC Vet Res       Date:  2011-08-16       Impact factor: 2.741

5.  Horizontal transmission and phylogenetic analysis of bovine leukemia virus in two districts of Miyazaki, Japan.

Authors:  Hirohisa Mekata; Satoshi Sekiguchi; Satoru Konnai; Yumi Kirino; Yoichiro Horii; Junzo Norimine
Journal:  J Vet Med Sci       Date:  2015-04-19       Impact factor: 1.267

6.  Sequencing and phylogenetic analysis of the gp51 gene from Korean bovine leukemia virus isolates.

Authors:  EunJung Lee; Eun-Ju Kim; Ha-Kyung Joung; Bo-Hye Kim; Jae-Young Song; In-Soo Cho; Kyoung-Ki Lee; Yeun-Kyung Shin
Journal:  Virol J       Date:  2015-04-15       Impact factor: 4.099

7.  Prevalence of bovine leukemia virus (BLV) infection in the northeast of Iran.

Authors:  Shalaleh Mousavi; Alireza Haghparast; Gholamreza Mohammadi; Seyed-Elias Tabatabaeizadeh
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

8.  Risk factors associated with within-herd transmission of bovine leukemia virus on dairy farms in Japan.

Authors:  Sota Kobayashi; Toshiyuki Tsutsui; Takehisa Yamamoto; Yoko Hayama; Ken-ichiro Kameyama; Misako Konishi; Kenji Murakami
Journal:  BMC Vet Res       Date:  2010-01-07       Impact factor: 2.741

9.  Bayesian Estimation of the True Seroprevalence and Risk Factor Analysis of Bovine Leukemia Virus Infection in Pakistan.

Authors:  Ali Sakhawat; Marzena Rola-Łuszczak; Zbigniew Osiński; Nazia Bibi; Jacek Kuźmak
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

10.  Effect of freezing treatment on colostrum to prevent the transmission of bovine leukemia virus.

Authors:  Toru Kanno; Ryoko Ishihara; Shinichi Hatama; Yasuhiro Oue; Hiroki Edamatsu; Yasuhiro Konno; Satoshi Tachibana; Kenji Murakami
Journal:  J Vet Med Sci       Date:  2013-09-26       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.